149 related articles for article (PubMed ID: 6118205)
1. Pharmacologic features and effects of neuroleptics.
Seeman MV
Can Med Assoc J; 1981 Oct; 125(8):821-6. PubMed ID: 6118205
[TBL] [Abstract][Full Text] [Related]
2. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic medication: clinical guidelines for maintenance therapy.
Johnson DA
J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
[TBL] [Abstract][Full Text] [Related]
4. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic.
Ereshefsky L
J Clin Psychiatry; 1999; 60 Suppl 10():20-30. PubMed ID: 10340684
[TBL] [Abstract][Full Text] [Related]
6. [Delayed-action neuroleptics and maintenance treatments].
Péron-Magnan P
Encephale; 1991; 17(4):263-6. PubMed ID: 1683627
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
8. [Two cases of tardive Tourette syndrome].
Yamauchi K; Ohmori T
Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
[TBL] [Abstract][Full Text] [Related]
9. Schizophrenia and antipsychotic drugs.
Nurnberg HG; Levine PE
Compr Ther; 1986 Oct; 12(10):42-52. PubMed ID: 2877767
[TBL] [Abstract][Full Text] [Related]
10. Depot neuroleptic therapy: clinical considerations.
Remington GJ; Adams ME
Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
[TBL] [Abstract][Full Text] [Related]
11. [New chemotherapy approaches to psychoses].
Olié JP; Baylé FJ
Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
[TBL] [Abstract][Full Text] [Related]
12. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
Turner MS; Stewart DW
J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985
[TBL] [Abstract][Full Text] [Related]
13. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
Johnson DA
J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
[TBL] [Abstract][Full Text] [Related]
14. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
Kristjansen P
Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
[No Abstract] [Full Text] [Related]
15. [Evaluation trial on the efficacy of neuroleptics on the outcome of schizophrenia].
Dollfus S; Petit M
Encephale; 1991; 17(4):247-53. PubMed ID: 1683625
[TBL] [Abstract][Full Text] [Related]
16. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].
Woggon B
Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040
[TBL] [Abstract][Full Text] [Related]
17. Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.
Tran-Johnson TK; Krull AJ; Jeste DV
Clin Geriatr Med; 1992 May; 8(2):401-10. PubMed ID: 1350940
[TBL] [Abstract][Full Text] [Related]
18. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
19. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
20. A pharmacological and theoretical comparison of high and low potency neuroleptics.
Zavodnick S
J Clin Psychiatry; 1978 Apr; 39(4):332-6. PubMed ID: 24619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
